WallStSmart
SLRN

ACELYRIN, INC. Common Stock

NASDAQ: SLRN · HEALTHCARE · BIOTECHNOLOGY

$2.27
+0.00% today

Updated 2026-06-04

Market cap
$229.17M
P/E ratio
P/S ratio
EPS (TTM)
$-2.69
Dividend yield
52W range
$0 – $0
Volume
4.1M

WallStSmart proprietary scores

32
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
8.5
Quality
A
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
5.7
Altman Z-Score
Safe zone
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$8.00
+252.42%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Altman Z 5.71 — safe zone
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-38.96M

Key financials

Revenue Net Income Free Cash Flow
Metric2021202220232024TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-41.84M$-250.46M$-381.64M$-248.23M$-55.26M
EPS$-2.69
Free cash flow$-29.98M$-61.52M$-182.00M$-305.17M$-38.96M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SLRN$229.17M324.33.05.08.5Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

ACELYRIN, INC. Common Stock trades at $2.27. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 5.71, it sits in the safe zone.

Frequently asked questions

What is ACELYRIN, INC. Common Stock's stock price?

ACELYRIN, INC. Common Stock (SLRN) trades at $2.27.

Is ACELYRIN, INC. Common Stock overvalued?

ACELYRIN, INC. Common Stock carries a Smart Value Score of 32/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of ACELYRIN, INC. Common Stock (SLRN)?

The 12-month analyst consensus target is $8.00, about 252.4% above the current $2.27. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

ACELYRIN, INC. Common Stock's Altman Z-Score is 5.71, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-65.94%
Beta1.09
50D MA$2.40
200D MA$3.55
Shares out0.10B
Float0.07B
Short ratio
Avg volume4.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years